Condition: Cirrhosis · Splenectomy · Portal Vein Thrombosis · Sponsor: Northern Jiangsu People's Hospital
The purpose of this study is to determine whether Apixaban is effective and safe in the treatment of portal vein thrombosis Occurring more than one year after laparoscopic splenectomy and azygoportal disconnection.
This description comes directly from the study's public registry record.
Guo-Qing Jiang, MD · +8651487373272 · jgqing2003@hotmail.com
Dou-Sheng Bai, MD · +8651487373275 · bdsno1@hotmail.com
Always discuss trial participation with your own doctor first.
| Clinical Medical College | Yangzhou, Jiangsu, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07461532